Second ESMO consensus conference on lung cancer: Pathology and molecular biomarkers for non-small-cell lung cancer

Keith M. Kerr, Lukas Bubendorf, Martin J. Edelman, Antonio Marchetti, Tony Mok, Silvia Novello, Ken O'Byrne, Rolf Stahel, Solange Peters, Enriqueta Felip, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz-Ares, Egbert F. Smit, Peter Meldgaard, Alex AdjeiMarianne Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre-Finn, Gaetano Rocco, Giulia Veronesi, Jean Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk de Ruysscher, Cecile Le Pechoux, Paul de Leyn, Virginie Westeel

Research output: Contribution to journalArticle

171 Scopus citations

Abstract

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The Second ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on management of patients with nonsmall- cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, early stage disease, locally advanced disease and advanced (metastatic) disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on recommendations for pathology and molecular biomarkers in relation to the diagnosis of lung cancer, primarily non-small-cell carcinomas.

Original languageEnglish (US)
Article numbermdu145
Pages (from-to)1681-1690
Number of pages10
JournalAnnals of Oncology
Volume25
Issue number9
DOIs
StatePublished - Sep 2014

Keywords

  • Consensus
  • ESMO
  • Molecular testing
  • Non-small-cell lung cancer
  • Pathology
  • Recommendations

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Second ESMO consensus conference on lung cancer: Pathology and molecular biomarkers for non-small-cell lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Kerr, K. M., Bubendorf, L., Edelman, M. J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S., Felip, E., Besse, B., Vansteenkiste, J., Eberhardt, W., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, E. F., Meldgaard, P., ... Westeel, V. (2014). Second ESMO consensus conference on lung cancer: Pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9), 1681-1690. [mdu145]. https://doi.org/10.1093/annonc/mdu145